Investigating the antiviral therapeutic potentialities of marine polycyclic lamellarin pyrrole alkaloids as promising inhibitors for SARS-CoV-2 and Zika main proteases (Mpro).

The new coronavirus variant (SARS-CoV-2) and Zika virus are two world-wide health pandemics. Along history, natural products-based drugs have always crucially recognized as a main source of valuable medications. Considering the SARS-CoV-2 and Zika main proteases () as the re-production key element of the viral cycle and its main target, herein we report an intensive computer-aided virtual screening for a focused list of 39 marine lamellarins pyrrole alkaloids, against SARS-CoV-2 and Zika main proteases () using a set of combined modern computational methodologies including molecular docking (), molecule dynamic simulations () and structure-activity relationships () as well. Indeed, the molecular docking studies had revealed four promising marine alkaloids including [lamellarin H ()/K ()] and [lamellarin S ()/Z ()], according to their notable ligand-protein energy scores and relevant binding affinities with the SARS-CoV-2 and Zika () pocket residues, respectively. Consequentially, these four chemical hits were further examined thermodynamically though investigating their simulations at 100 ns, where they showed prominent stability within the accommodated () pockets. Moreover, in-deep SARs studies suggested the crucial roles of the rigid fused polycyclic ring system, particularly aromatic A- and F- rings, position of the phenolic -OH and δ-lactone functionalities as essential structural and pharmacophoric features. Finally, these four promising lamellarins alkaloids were investigated for their ADME using the SWISS ADME platform, where they displayed appropriated drug-likeness properties. Such motivating outcomes are greatly recommending further examinations regarding those lamellarins pyrrole alkaloids ().Communicated by Ramaswamy H. Sarma.